Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemias.

Blood
Pankaj GuptaChien-Hsing Chang

Abstract

We have generated hexavalent antibodies (HexAbs) comprising 6 Fabs tethered to one Fc of human IgG1. Three such constructs, 20-20, a monospecific HexAb comprising 6 Fabs of veltuzumab (humanized anti-CD20 immunoglobulin G1κ [IgG1κ]), 20-22, a bispecific HexAb comprising veltuzumab and 4 Fabs of epratuzumab (humanized anti-CD22 IgG1κ), and 22-20, a bispecific HexAb comprising epratuzumab and 4 Fabs of veltuzumab, were previously shown to inhibit pro-liferation of several lymphoma cell lines at nanomolar concentrations in the absence of a crosslinking antibody. We now report an in-depth analysis of the apoptotic and survival signals induced by the 3 HexAbs in Burkitt lymphomas and provide in vitro cytotoxicity data for additional lymphoma cell lines and also chronic lymphocytic leukemia patient specimens. Among the key findings are the significant increase in the levels of phosphorylated p38 and phosphatase and tensin homolog deleted on chromosome 10 (PTEN) by all 3 HexAbs and the notable differences in the signaling events triggered by the HexAbs from those incurred by crosslinking veltuzumab or rituximab with a secondary antibody. Thus, the greatly enhanced direct toxicity of these HexAbs correlates with their ability to alter ...Continue Reading

References

Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·U D Staerz, M J Bevan
Feb 1, 1997·Nature Biotechnology·M J Coloma, S L Morrison
Sep 6, 2001·Biomolecular Engineering·J KriangkumM R Suresh
Dec 4, 2002·Nature Reviews. Immunology·Hiroaki Niiro, Edward A Clark
Apr 23, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rhona SteinDavid M Goldenberg
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John P LeonardDavid M Goldenberg
Feb 17, 2006·The Journal of Biological Chemistry·Juqun ShenZhenping Zhu
Apr 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Edmund A RossiChien-Hsing Chang
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sreeram MaddipatlaMyron S Czuczman
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chien-Hsing ChangDavid M Goldenberg
Apr 23, 2008·The Journal of Biological Chemistry·Claire A WalsheMark S Cragg
Aug 16, 2008·Cancer Immunology, Immunotherapy : CII·Constantin N BaxevanisMichael Papamichail
Sep 2, 2008·Nature Reviews. Drug Discovery·Mark E DavisDong M Shin
Oct 17, 2008·Cancer Research·Edmund A RossiChien-Hsing Chang
Nov 5, 2008·Biotechnology and Bioengineering·Leonard F PeaseMichael J Tarlov
May 23, 2009·British Journal of Pharmacology·Patrick ChamesDaniel Baty
Jun 11, 2009·Cancer Research·Patrick A Baeuerle, Carsten Reinhardt

❮ Previous
Next ❯

Citations

Nov 3, 2012·Bioconjugate Chemistry·Edmund A RossiDavid M Goldenberg
Mar 29, 2013·Nature Reviews. Drug Discovery·Jean G SathishB Kevin Park
May 21, 2014·PloS One·Edmund A RossiDavid M Goldenberg
Jan 1, 2010·Clinical & Developmental Immunology·Giulia MottaAlessio Nencioni
Mar 19, 2014·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ron D JachimowiczAchim Rothe
Sep 18, 2014·Journal of Hematology & Oncology·Alexandra AroninMichal Elhalel
Jun 29, 2012·Trends in Pharmacological Sciences·Edmund A RossiChien-Hsing Chang
Jul 19, 2012·European Journal of Haematology·Tsuyoshi NakamakiHidekazu Ota
Aug 6, 2013·Transplant International : Official Journal of the European Society for Organ Transplantation·Menna R Clatworthy
Jun 11, 2011·Biochemical Pharmacology·Camilla JandusStephan von Gunten
Mar 29, 2012·MAbs·Roland E Kontermann
Mar 29, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yong-Xian HuHe Huang
Nov 8, 2015·The Lancet Oncology·Yanni ZhuKhalid Shah
Jan 11, 2017·MAbs·Ulrich Brinkmann, Roland E Kontermann
Feb 28, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Josée GolayMartine Duonor-Cérutti
Jul 31, 2020·International Journal of Molecular Sciences·Fabiana ConciatoriMichele Milella
Nov 1, 2011·Molecular Cancer Therapeutics·Robert M SharkeyDavid M Goldenberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.